Loss per share (Tables)

3 Months Ended

Mar. 31, 2025

Schedule of diluted net loss per share attributable to common stockholders

The Company excluded the following potential common shares presented based on amounts outstanding at period end from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:


	As of March 31,
	2025	2024
Anti-dilutive common stock equivalents:
Options to purchase common stock	13,893,266	11,428,285

Total anti-dilutive common stock equivalents	13,893,266	11,428,285

Schedule of basic and diluted loss per share

Basic and diluted loss per share is computed by dividing net loss by the weighted-average common shares outstanding for the three months ended March 31, 2025 and 2024 (in thousands, except share and per share data):


	Three Months Ended March 31,
	2025		2024
Numerator:
Net loss	$	(26,322)	$	(28,361)
Denominator:
Weighted-average number of shares used in computed net loss per share − basic and diluted	70,833,044		68,432,168
Net loss per share − basic and diluted	$	(0.37)	$	(0.41)